Novartis to expand radiopharmaceuticals portfolio with $2.1bn Endocyte acquisition

Swiss pharmaceutical company Novartis has announced a strategic acquisition of the US-based biopharma firm Endocyte for approximately $2.1 billion. This move aims to bolster Novartis’s ... Read More